Word

BLANENSE

Status

Dead

Status Code

710

Status Date

Friday, March 10, 2023

Serial Number

85775773

Registration Number

5029437

Registration Date

Tuesday, August 30, 2016

Mark Type

4000

Filing Date

Friday, November 9, 2012

Published for Opposition

Tuesday, May 7, 2013

Cancellation Date

Friday, March 10, 2023

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Mar 10, 2023

Cancelled Sec. 8 (6-Yr)

Aug 1, 2022

Teas Change Of Correspondence Received

Aug 1, 2022

Teas Change Of Domestic Representatives Address

Aug 1, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 1, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 30, 2021

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Aug 30, 2016

Registered-Principal Register

Jul 27, 2016

1(B) Basis Deleted; Proceed To Registration

May 23, 2016

Notice Of Allowance Cancelled

May 23, 2016

Teas Delete 1(B) Basis Received

Dec 22, 2015

Notice Of Approval Of Extension Request E-Mailed

Dec 21, 2015

Sou Extension 5 Granted

Dec 9, 2015

Sou Extension 5 Filed

Dec 9, 2015

Teas Extension Received

Jun 22, 2015

Teas Change Of Correspondence Received

Jun 17, 2015

Notice Of Approval Of Extension Request E-Mailed

Jun 16, 2015

Sou Extension 4 Granted

Jun 1, 2015

Sou Extension 4 Filed

Jun 15, 2015

Case Assigned To Intent To Use Paralegal

Jun 1, 2015

Teas Extension Received

Dec 10, 2014

Notice Of Approval Of Extension Request E-Mailed

Dec 9, 2014

Sou Extension 3 Granted

Dec 2, 2014

Sou Extension 3 Filed

Dec 2, 2014

Teas Extension Received

Jul 17, 2014

Notice Of Approval Of Extension Request E-Mailed

Jul 16, 2014

Sou Extension 2 Granted

Jun 23, 2014

Sou Extension 2 Filed

Jul 15, 2014

Case Assigned To Intent To Use Paralegal

Jun 23, 2014

Teas Extension Received

Dec 18, 2013

Notice Of Approval Of Extension Request E-Mailed

Dec 16, 2013

Sou Extension 1 Granted

Dec 16, 2013

Sou Extension 1 Filed

Dec 16, 2013

Teas Extension Received

Jul 2, 2013

Noa E-Mailed - Sou Required From Applicant

May 7, 2013

Official Gazette Publication Confirmation E-Mailed

May 7, 2013

Published For Opposition

Apr 17, 2013

Notification Of Notice Of Publication E-Mailed

Mar 29, 2013

Law Office Publication Review Completed

Mar 26, 2013

Assigned To Lie

Mar 20, 2013

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 20, 2013

Teas Change Of Owner Address Received

Mar 11, 2013

Approved For Pub - Principal Register

Mar 11, 2013

Examiner's Amendment Entered

Mar 11, 2013

Notification Of Examiners Amendment E-Mailed

Mar 11, 2013

Examiners Amendment E-Mailed

Mar 11, 2013

Examiners Amendment -Written

Mar 7, 2013

Assigned To Examiner

Nov 16, 2012

New Application Office Supplied Data Entered

Nov 13, 2012

New Application Entered